April 15 (UPI) -- The Food and Drug Administration is considering lifting restrictions on some peptide injections, supplements heralded by Health and Human Services Secretary Robert F. Kennedy Jr., a notice in the Federal Register posted Wednesday indicated.
It would be the first step in possibly allowing compounding pharmacies to manufacture seven peptides used to treat ulcerative colitis, wound healing, obesity, insomnia and other conditions, the notice read.
The FDA's expert advisory panel on pharmacy compounding is set to meet about the approval of peptides in late July. The Pharmacy Compounding Advisory Committee also plans to consider another five peptides before February 2027.
The FDA currently restricts the use of the injections due to safety concerns and a lack of testing, The Hill reported.
Related
